Clinical Trials Directory

Trials / Terminated

TerminatedNCT04680533

Wireless TENS for Peripheral Edema (Lower Limb Swelling)

Transcutaneous Electrical Nerve Stimulation for Peripheral Edema: A Single Arm Clinical Trial

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
3 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is single center, subject will receive a wireless TENS device. All subjects will be allowed to keep the commercially-available device for use after the study. The primary goal is to test the feasibility of the study design and secondary is to test the preliminary efficacy of the TENS.

Detailed description

This study is single center, subject will receive a wireless TENS device. The coordinator will introduce the study device, be available to answer questions about the device, and assess adverse events. Subjects will be told that we are testing whether TENS, which has shown promise in some patients but needs to be tested formally, has an effects on lower limb swelling . The treatment period will be 3 weeks in duration. After the treatment period, all subjects will be asked to complete the Treatment-period Endpoint-Qualitative interview. All subjects will be allowed to keep the commercially-available device for use after the study.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous Electrical Nerve Stimulation (TENS)Quell TENS device. The device is worn on the upper calf right below the knee and secured by an elastic band. The device is controlled by an App and alternates between treatment periods and rest periods. Participants will be asked to wear the device 7-8 hours per day alternating legs.

Timeline

Start date
2021-06-28
Primary completion
2024-02-22
Completion
2024-02-22
First posted
2020-12-23
Last updated
2025-12-03
Results posted
2025-12-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04680533. Inclusion in this directory is not an endorsement.